DEA and HHS Further Extend Telemedicine Rules for Prescribing Controlled Substances

The U.S. Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have issued a fourth temporary extension[1] (the “Fourth Temporary Extension”) of rules that allow providers to prescribe controlled substances via telemedicine without an initial in-person exam through December 31, 2026. These rules, first introduced during the COVID-19 public health emergency,…

Does your healthcare practice use employment agreements with non-compete provisions? If so, your practice may be a target of the FTC.

By: Desalina A. Williams and Jodi R. Bohr In 2024, the Federal Trade Commission (the “FTC” or “Commission”) finalized a rule that prohibited noncompete clauses in employment agreements.[1] This rule sparked significant discourse across various industries. However, the rule was never enforced because a Texas federal court issued a nationwide injunction blocking the FTC’s rule…

Welcome Jodi Bohr!

Milligan Lawless is very pleased to announce that Jodi Bohr has joined the firm as a Shareholder. With over 20 years of experience, Jodi provides counsel to clients on a broad range of employment matters, including: compliance with state and federal employment laws; conducting workplace investigations; and performance management and HR best practices. Jodi counsels…